Advertisement

---

BIODELIVERY SCIENCES INTERNATIONAL, INC.

BioDelivery Sciences to Present at the 8th Annual JMP Securities Healthcare Conference

[2013-07-03] -


BioDelivery Sciences Announces NDA Submission for BUNAVAIL on Track Following Positive Pre-NDA Meeting with FDA

[2013-06-10] - BUNAVAIL NDA submission continues on target for mid-summer 2013


BioDelivery Sciences to Present at the William Blair 33rd Annual Growth Stock Conference

[2013-06-05] -


BioDelivery Sciences to Present at the Jefferies 2013 Global Healthcare Conference

[2013-05-28] -


BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of First Quarter 2013 Financials

[2013-05-09] - NDA filing for BUNAVAIL on track for mid-summer 2013
Phase 3 clinical trials for BEMA Buprenorphine in conjunction with Endo to complete in late 2013 or early 2014
Clonidine Topical Gel recently in-licensed and has $300 million plus commercial potential


Advertisement
Most read: scientific news

More:

---


---
Follow us...

google plus Facebook twitter Newsletter

---


---

Plan du site

Actualités

Actualités

Actualités

Réglementaire

Emploi

Annuaires

Dictionnaire

Divers